【レポートの概要(一部)】
01. Executive Summary
02.List of Abbreviations
03.Scope of the Report
03.1 Market Overview
03.2 Product Offerings
04.Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology
05.Introduction
06.Market Landscape
06.1 Market Overview
06.2 Market Size and Forecast
06.3 Five Forces Analysis
07.Market Segmentation by Product
07.1 Global Hematology Analyzers Market
07.1.1 Market Size and Forecast
07.2 Global Hematology Reagents Market
07.2.1 Market Size and Forecast
08.Geographical Segmentation
08.1 Hematology Analyzers and Reagents Market in Americas
08.1.1 Market Size and Forecast
08.2 Hematology Analyzers and Reagents Market in EMEA Region
08.2.1 Market Size and Forecast
08.3 Hematology Analyzers and Reagents Market in APAC Region
08.3.1 Market Size and Forecast
09.Buying Criteria
10.Market Growth Drivers
11.Drivers and their Impact
12.Market Challenges
13.Impact of Drivers and Challenges
14.Market Trends
15.Trends and their Impact
16.Vendor Landscape
16.1 Competitive Scenario
16.1.1 Key News
16.2 Vendor Analysis 2014
16.3 Other Prominent Vendors
17.Key Vendor Analysis
17.1 Abbott Laboratories
17.1.1 Key Facts
17.1.2 Business Description
17.1.3 Business Segmentation
17.1.4 Business Strategy
17.1.5 Revenue by Business Segmentation
17.1.6 Revenue Comparison 2011 and 2012
17.1.7 Revenue by Geographical Segmentation
17.1.8 Key Information
17.1.9 SWOT Analysis
17.2 Beckman Coulter
17.2.1 Key Facts
17.2.2 Business Overview
17.2.3 Business Segmentation 2013
17.2.4 Geographical Segmentation by Revenue 2013
17.2.5 Business Strategy
17.2.6 Recent Developments
17.2.7 SWOT Analysis
17.3 Sysmex
17.3.1 Key Facts
17.3.2 Business Overview
17.3.3 Product Segmentation by Revenue 2014
17.3.4 Product Segmentation by Revenue 2013 and 2014
17.3.5 Geographical Segmentation by Revenue 2014
17.3.6 Business Strategy
17.3.7 Recent Developments
17.3.8 SWOT Analysis
18.Other Reports in this Series
[List of Exhibits]
Exhibit 1: Market Research Methodology
Exhibit 2: Global Hematology Analyzers and Reagents Market 2014-2019 (US$ million)
Exhibit 3: Segmentation of Global Hematology Analyzers and Reagents Market 2014
Exhibit 4: Global Hematology Analyzers Market 2014-2019 (US$ million)
Exhibit 5: Global Hematology Reagents Market 2014-2019 (US$ million)
Exhibit 6: Segmentation of Global Hematology Analyzers and Reagents Market by Geography 2014
Exhibit 7: Hematology Analyzers and Reagents Market in Americas 2014-2019 (US$ million)
Exhibit 8: Hematology Analyzers and Reagents in EMEA Region 2014-2019 (US$ million)
Exhibit 9: Hematology Analyzers and Reagents Market in APAC Region 2014-2019 (US$ million)
Exhibit 10: Segmentation of Global Hematology Analyzers and Reagents Market by Geography 2014-2019
Exhibit 11: Global Hematology Analyzers and Reagents Market Segmentation by Vendor Share
Exhibit 12: Abbott Laboratories Inc.: Business Segmentation
Exhibit 13: Abbott Laboratories Inc.: Revenue by Business Segmentation 2012
Exhibit 14: Abbott Laboratories Inc.: Revenue by Business Segmentation 2011 and 2012 (US$ million)
Exhibit 15: Abbott Laboratories Inc.: Revenue by Geographical Segmentation 2012
Exhibit 16: Beckman Coulter: Business Segmentation 2013
Exhibit 17: Beckman Coulter: Geographical Segmentation by Revenue 2013
Exhibit 18: Sysmex: Product Segmentation by Revenue 2014
Exhibit 19: Sysmex: Product Segmentation by Revenue 2013 and 2014 (US$ million)
Exhibit 20: Sysmex: Geographical Segmentation by Revenue 2014
【レポート販売概要】
■ タイトル:血液分析装置・試薬の世界市場2015-2019■ 英文:Global Hematology Analyzers and Reagents Market 2015-2019
■ 発行日:2015年1月21日
■ 調査会社:Technavio
■ 商品コード:IRTNTR5072
■ 調査対象地域:グローバル
- 脳電図(EEG)/筋電図(EMG)装置の世界市場About EEG and EMG Equipment EEG and EMG equipment are used to monitor and record electrical activity in the brain and muscles, respectively. The most important clinical use of EEG is in the diagnosis of epilepsy. It is also used to diagnose brain dysfunction, sleep disorders, dementia, coma, and brain death. Earlier, EEG was also used often in the diagnosis of brain tumor and head injury. However, …
- ウエストナイルウイルス感染症(West Nile Virus Infections):世界の治験レビュー2014年下半期版West Nile Virus Infections Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “West Nile Virus Infections Global Clinical Trials Review, H2, 2014" provides data on the West Nile Virus Infections clinical trial scenario. This report provides elemental information and data relating to the clinical trials on West Nile Virus Infections. It includes an overview of the t …
- 手術器具追跡システムの世界市場分析:製品別(ハードウェア、ソフトウェア、サービス)、技術別(バーコード、RFID)、エンドユーザー別、地域別(北アメリカ、ヨーロッパ、アジア太平洋、ラテンアメリカ、MEA)、セグメント予測、2014-2025The global surgical instrument tracking systems market is expected to reach a value of USD 442.9 million by 2025, according to a new report by Grand View Research, Inc. Increasing incidence of surgical instruments being left behind after surgery is the most significant factor anticipated to boost the market growth during the forecast period. Annually in the U.S, around 4,500 to 6,000 surgical inst …
- Low Cardiac Output Syndrome:グローバル臨床試験レビューH1, 2013Low Cardiac Output Syndrome Global Clinical Trials Review, H1, 2013 Summary GlobalData's clinical trial report, “Low Cardiac Output Syndrome Global Clinical Trials Review, H1, 2013" provides data on the Low Cardiac Output Syndrome clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Low Cardiac Output Syndrome. It includes an overview of t …
- バイオポリマーの世界市場2017-2021About Biopolymers Polymers, which are petrochemical derivatives, account for about 80% of the total polymeric materials globally produced. Polymer production has been a cause of concern to nations worldwide. The dependency on the petrochemical industry had been irreplaceable until the discovery of biopolymers two decades ago. The emergence of biopolymers is seen as a step toward sustainable develo …
- Amitifadine (大うつ病性障害):医薬品市場予測及び分析(~2023)Amitifadine (Major Depressive Disorder) - Forecast and Market Analysis to 2023 Summary Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. The MDD market is a crowded and competitive market, with more than 30 marketed products available for the treatment of patients with MDD. The depression market is about to enter a dynamic phase with imminent patent expiries …
- 湾岸協力会議(GCC)活性炭の世界市場分析:製品別(粉体、粒体)、用途別(液相、気相)、エンドユーザー別(水処理(飲料水、排水)、製油所、食品・飲料処理、医薬品・医療、空気浄化、貴金属回収、下水処理)、セグメント予測The gulf cooperation council (GCC) activated carbon market is expected to reach USD 330.3 million by 2024, according to a new report by Grand View Research, Inc. Activated carbon is a porous material which is used to adsorb contaminants. Increasing water treatment processes in the GCC region is expected to drive activated carbon market demand. GCC countries experience water scarcity due to low rai …
- TCMS(列車制御・管理システム)の世界市場予測(~2021年):車両制御ユニット、モバイル通信ゲートウェイ、HMIThe global Train Control And Management System (TCMS) Market is projected to grow at a CAGR of 7.72% from 2016 to 2021, to reach a market size of USD 3.28 Billion by 2021. The growing inclination towards rapid, safe, and comfortable transport, increasing urbanization, and stringent emission norms have fueled the growth of the TCMS market. The North American TCMS market is projected to grow at the …
- 心血管装置の世界市場分析:製品別(診断モニタリング:ECG、ホルターモニター、イベントモニター、診断カテーテル、埋め込み型ループレコーダー、心エコー検査、PETスキャン、MRI、心臓CT、心筋灌流スキャン、ドップラー胎児モニター;外科手術:ペースメーカー、ステント、カテーテル・アクセサリー、ガイドワイヤー、カニューレ、電気外科処置、バルブ、閉塞器具)、セグメント予測Global cardiovascular devices market is anticipated to reach USD 121 billion by 2024, according to a new report by Grand View Research, Inc. Increasing geriatric population, sedentary life style coupled with unhealthy dietary habits is spurring the prevalence of cardiovascular diseases. Constant rise in the patients suffering from cardiovascular diseases and is expected to drive market growth duri …
- 再生医療の世界市場:細胞治療、組織スキャフォールド、遺伝子治療About the Regenerative Medicine Market Regenerative medicine is a process of regenerating cells, tissues, and organs to restore normal function in a diseased organ. This branch of tissue engineering and molecular biology is promising and is driven by demand from patients, development of cell therapy, tissue scaffold, and gene therapy products, and increase in the number of pipeline products. Techn …
- タンタルの世界市場2015-2019About Tantalum Tantalum is a heavy, hard, and grey metallic element. It is resistant to chemical attacks at temperatures below 150°C. Tantalum is a rare earth metal and is not found in large amounts. Tantalum exhibits resistance to corrosion due to presence of an oxide film on its surface. Melting point of tantalum is quite high and is lower only to tungsten and rhenium. The metal exhibits maximum …
- 世界のアクチュエーター市場動向及び予測(2014-2019)The global actuators market is estimated to be $37.38 billion in 2014, and it is expected to grow at a CAGR of 8.00% to reach $54.93 billion by 2019. The actuators market overall has numerous competitors in each sector such as industry automobile, health care, aerospace & defense, marine, and mining. The primary market players are from the U.S. and Europe; the players from these regions have the t …
- フィールドサービス管理ソリューションの世界市場予測(~2021年)The global Field Service Management (FSM) market is expected to grow from USD 1.78 Billion in 2016 to USD 3.61 Billion by 2021, at a Compound Annual Growth Rate (CAGR) of 15.1% during the forecast period. The increased focus on scalable centralized system, increased usage of mobile devices for collaboration & real-time collaboration, and growing need for improved enterprise efficiencies is driving …
- 世界の製鋼市場(2014-2018)About Steel Steel is the main engineering material used in industries such as Construction, Automotive, Transport, Power, Mechanical Machinery, Metal Goods, and Domestic Appliances. It is also the main material utilized in delivering renewable energy such as solar, tidal, and wind power. Steel is composed of iron, carbon, impurities, and alloying elements, the combination of which determines the p …
- ファブリー病治療薬の世界市場About Fabry Disease Fabry disease is an inheritable lysosomal storage disease characterized by the excessive accumulation of globotriaosylceramide (GL-3) in lysosomes. It results from a deficiency of a-Gal and can result in symptoms such as fatigue, angiokeratoma, tinnitus, kidney failure, heart disorders, and nervous system problems. Fabry disease results from mutations in the galactosidase (GLA) …